✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Vivanza Biosciences Ltd.

VIVANZA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹9 Cr.
P/E
0.00

Vivanza Biosciences Ltd.

  • Vivanza Biosciences
  • Tiaan Consumer
  • Devine Impex

FAQs on Vivanza Biosciences Ltd. Shareprice

Vivanza Biosciences has given lower returns compared to its competitors.
Vivanza Biosciences has grown at ~-12.72% over the last 8yrs while peers have grown at a median rate of 9.73%

Vivanza Biosciences is not expensive.
Latest PE of Vivanza Biosciences is 0.0, while 3 year average PE is 96.93.
Also latest EV/EBITDA of Vivanza Biosciences is 0.0 while 3yr average is 141.

View FAQ's On Business

Growth Table

  • Vivanza Biosciences Ltd.
  • Tiaan Consumer
  • Devine Impex

Balance Sheet

  • Vivanza Biosciences Ltd.
  • Tiaan Consumer
  • Devine Impex

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vivanza Biosciences Ltd.
  • Tiaan Consumer
  • Devine Impex

Cash Flow

  • Vivanza Biosciences Ltd.
  • Tiaan Consumer
  • Devine Impex

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vivanza Biosciences Ltd.
  • Tiaan Consumer
  • Devine Impex

Quarterly Results

  • Vivanza Biosciences Ltd.
  • Tiaan Consumer
  • Devine Impex

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vivanza Biosciences Ltd. Financials

Vivanza Biosciences balance sheet is weak and might have solvency issues

Yes, The net debt of Vivanza Biosciences is increasing.
Latest net debt of Vivanza Biosciences is ₹9.53 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹8.53 Crs.

No, profit is decreasing.
The profit of Vivanza Biosciences is -₹0.67 Crs for Mar 2025, ₹0.55 Crs for Mar 2024 and ₹0.6 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vivanza Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech